Population-Based Screening Using Low-Dose Chest Computed Tomography: A Systematic Review of Health Economic Evaluations
CM Behr, MJ Oude Wolcherink, MJ IJzerman… - …, 2023 - Springer
Background Chest low-dose computed tomography (LDCT) is a promising technology for
population-based screening because it is non-invasive, relatively inexpensive, associated …
population-based screening because it is non-invasive, relatively inexpensive, associated …
Applying utility values in cost-effectiveness analyses of lung cancer screening: a review of methods
Lung cancer screening with low-dose computed tomography (LDCT) in high-risk
populations has been shown in randomised controlled trials to lead to early diagnosis and …
populations has been shown in randomised controlled trials to lead to early diagnosis and …
Cost-Effectiveness Analysis of Risk Factor-Based Lung Cancer Screening Program by Low-Dose Computer Tomography in Current Smokers in China
T Zhang, X Chen, C Li, X Wen, T Lin, J Huang, J He… - Cancers, 2023 - mdpi.com
Simple Summary Low-dose computed tomography (LDCT) has become the standard
approach for lung cancer screening, but the definition of populations at high risk of lung …
approach for lung cancer screening, but the definition of populations at high risk of lung …
Cost effectiveness of lung cancer screening with low-dose CT in heavy smokers in China
J Yuan, Y Sun, K Wang, Z Wang, D Li, M Fan… - Cancer Prevention …, 2022 - AACR
Although lung cancer screening with low-dose CT (LDCT) can reduce lung cancer mortality
by 20%, without an appropriate eligibility criteria, it may result in a waste of medical …
by 20%, without an appropriate eligibility criteria, it may result in a waste of medical …
Risk-based lung cancer screening in heavy smokers: a benefit–harm and cost-effectiveness modeling study
Y Liu, H Xu, L Lv, X Wang, R Kang, X Guo, H Wang… - BMC medicine, 2024 - Springer
Background Annual screening through low-dose computed tomography (LDCT) is
recommended for heavy smokers. However, it is questionable whether all individuals …
recommended for heavy smokers. However, it is questionable whether all individuals …
Lung Cancer Screening in Brazil Comparing the 2013 and 2021 USPSTF Guidelines
Importance It is estimated that, from 2023 to 2025, lung cancer (LC) will be the second most
frequent cancer in Brazil, but the country does not have an LC screening (LCS) policy …
frequent cancer in Brazil, but the country does not have an LC screening (LCS) policy …
The Swiss Approach-feasibility of a national low-dose CT lung cancer screening program
L Jungblut, C von Garnier, M Puhan… - Swiss medical …, 2022 - zora.uzh.ch
BACKGROUND Lung cancer is the leading cause of cancer-related deaths in Switzerland.
Despite this, there is no lung cancer screening program in the country. In the United States …
Despite this, there is no lung cancer screening program in the country. In the United States …
Systematic review of the cost-effectiveness of screening for lung cancer with low dose computed tomography
Objectives Lung cancer (LC) remains a burden for patients and healthcare systems, with
most cases only diagnosed once disease is late stage. Screening for LC with low-dose …
most cases only diagnosed once disease is late stage. Screening for LC with low-dose …
[PDF][PDF] Low-dose CT screening for lung cancer
S Aghlmandi, A Bhadhuri, HC Bucher, K de Nijs… - 2022 - edoc.unibas.ch
Sco**: DG, HCB; Systematic review: HCB and YT wrote the protocol; HE with assistance
from HCB developed and conducted the literature search; VG and HCB screened the …
from HCB developed and conducted the literature search; VG and HCB screened the …
Cost-Effectiveness Analyses of Lung Cancer Screening Using Low-Dose Computed Tomography: A Systematic Review Assessing Strategy Comparison and Risk …
M Fabbro, K Hahn, O Novaes, M Ó'Grálaigh… - PharmacoEconomics …, 2022 - Springer
Objectives Our first study objective was to assess the range of lung cancer screening
intervals compared within cost-effectiveness analyses (CEAs) of low-dose computed …
intervals compared within cost-effectiveness analyses (CEAs) of low-dose computed …